Hydroxychloroquine use was evenly distributed across the United States, but outpatient use of ivermectin was significantly higher in southern states.
During pandemic, ivermectin use rose 10-fold, hydroxychloroquine use doubled, study reveals
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Studies: 1 in 7 US working-age adults report long COVID, with heaviest burden on the poor
- Reports: Paxlovid doesn’t relieve adult long-COVID symptoms, prevent condition in youth
- Flu levels in US continue to decline, but more kids’ deaths confirmed
- Health leaders from multiple prior administrations sound alarm over CDC cuts